PlainRecalls
FDA Drug Moderate Class II Terminated

Duloxetine Delayed-release Capsules USP, 20 mg, 50 Capsules (5 x 10) Unit Dose per carton, unit dose blister UPC 5026828311), Rx only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-283-15.

Reported: November 8, 2017 Initiated: October 6, 2017 #D-0055-2018

Product Description

Duloxetine Delayed-release Capsules USP, 20 mg, 50 Capsules (5 x 10) Unit Dose per carton, unit dose blister UPC 5026828311), Rx only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-283-15.

Reason for Recall

Failed Impurities/Degradation Specifications: slightly elevated levels of phthalic acid.

Details

Recalling Firm
AVKARE Inc.
Units Affected
274 cartons
Distribution
Nationwide in the USA
Location
Pulaski, TN

Frequently Asked Questions

What product was recalled?
Duloxetine Delayed-release Capsules USP, 20 mg, 50 Capsules (5 x 10) Unit Dose per carton, unit dose blister UPC 5026828311), Rx only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-283-15.. Recalled by AVKARE Inc.. Units affected: 274 cartons.
Why was this product recalled?
Failed Impurities/Degradation Specifications: slightly elevated levels of phthalic acid.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 8, 2017. Severity: Moderate. Recall number: D-0055-2018.